Blom Johannes, Yin Li, Lidén Annika, Dolk Anders, Jeppsson Bengt, Påhlman Lars, Holmberg Lars, Nyrén Olof
Division of Surgery, Department for Clinical Science, Intervention and Technology, Karolinska Institutet at Karolinska University Hospital, K53, Huddinge, 141 86 Stockholm, Sweden.
Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1163-8. doi: 10.1158/1055-9965.EPI-07-2764.
Self-selection may compromise cost-effectiveness of screening programs. We hypothesized that nonparticipants have generally higher morbidity and mortality than participants.
A Swedish population-based random sample of 1,986 subjects ages 59 to 61 years was invited to sigmoidoscopy screening and followed up for 9 years by means of multiple record linkages to health and population registers. Gender-adjusted cancer incidence rate ratio (IRR) and overall and disease group-specific and mortality rate ratio (MRR) with 95% confidence intervals (95% CI) were estimated for nonparticipants relative to participants. Cancer and mortality rates were also estimated relative to the age-matched, gender-matched, and calendar period-matched Swedish population using standardized incidence ratios and standardized mortality ratios.
Thirty-nine percent participated. The incidence of colorectal cancer (IRR, 2.2; 95% CI, 0.8-5.9), other gastrointestinal cancer (IRR, 2.7; 95% CI, 0.6-12.8), lung cancer (IRR, 2.2; 95% CI, 0.8-5.9), and smoking-related cancer overall (IRR, 1.4; 95% CI, 0.7-2.5) tended to be increased among nonparticipants relative to participants. Standardized incidence ratios for most of the studied cancers tended to be >1.0 among nonparticipants and <1.0 among participants. Mortality from all causes (MRR, 2.4; 95% CI, 1.7-3.4), neoplastic diseases (MRR, 1.9; 95% CI, 1.1-3.5), gastrointestinal cancer (MRR, 4.7; 95% CI, 1.1-20.7), and circulatory diseases (MRR, 2.3; 95% CI, 1.2-4.2) was significantly higher among nonparticipants than among participants. Standardized mortality ratio for the studied outcomes tended to be increased among nonparticipants and was generally decreased among participants.
Individuals who might benefit most from screening are overrepresented among nonparticipants. This self-selection may attenuate the cost-effectiveness of screening programs on a population level.
自我选择可能会损害筛查项目的成本效益。我们假设未参与者的发病率和死亡率总体上高于参与者。
基于瑞典人群的1986名年龄在59至61岁之间的受试者随机样本被邀请进行乙状结肠镜检查筛查,并通过与健康和人口登记册的多重记录链接进行了9年的随访。相对于参与者,估计了未参与者的性别调整癌症发病率比(IRR)以及总体和疾病组特异性死亡率比(MRR)及其95%置信区间(95%CI)。还使用标准化发病率和标准化死亡率相对于年龄匹配、性别匹配和日历期匹配的瑞典人群估计了癌症和死亡率。
39%的人参与了。未参与者中结直肠癌(IRR,2.2;95%CI,0.8 - 5.9)、其他胃肠道癌症(IRR,2.7;95%CI,0.6 - 12.8)、肺癌(IRR,2.2;95%CI,0.8 - 5.9)以及总体吸烟相关癌症(IRR,1.4;95%CI,0.7 - 2.5)的发病率相对于参与者往往有所增加。大多数研究癌症的标准化发病率在未参与者中往往>1.0,而在参与者中<1.0。未参与者的全因死亡率(MRR,2.4;95%CI,1.7 - 3.4)、肿瘤性疾病(MRR,1.9;95%CI,1.1 - 3.5)、胃肠道癌症(MRR,4.7;95%CI,1.1 - 20.7)和循环系统疾病(MRR,2.3;95%CI,1.2 - 4.2)显著高于参与者。研究结果的标准化死亡率在未参与者中往往增加,而在参与者中总体下降。
在未参与者中,可能从筛查中获益最大的个体比例过高。这种自我选择可能会削弱筛查项目在人群层面的成本效益。